Apidra, solution injectable - 5 x 3 ml Swissmedic Key 57013002 Registration Holder Sanofi-Aventis (Suisse) SA Name Apidra, solution injectable Date of registration 02.05.2005 Introduction of Sequence 02.05.2005 ATC-Classification Insulin Glulisine (A10AB06) Revision date 28.04.2006 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.10. Show package size 5 x 3 ml Index Therapeuticus (Swissmedic) 07.06.10. Description Kartuschen für Pen Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 37.28 Limitation No Deductible 10 % Consumer price 56.95 Feedback FB Daily cost GTIN 7680570130029 Medication Code Biotechnologika Pharmacode 2978750 Disponibility
Composition insulinum glulisinum 3.49 mg corresp. insulinum glulisinum 100 U., metacresolum, trometamolum, natrii chloridum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.97 mg. Packungsbestandteile Galenic Form Injektionslösung Excipiens Active Agent Dose Insulinum Glulisinum 3.49 mg/ml correspond Insulinum Glulisinum 100 U/ml
BAG: Active Agent Dose Insulinum Glulisinum 100 U
Inactive agents Acidum Hydrochloridum Metacresolum Natrii Chloridum Natrii Hydroxidum Polysorbatum 20 Trometamolum
Source Data was imported : 07.05.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
